MHRA staff lack skills to regulate medicines - Hedley Rees, Pharmaflow, Philip Hyland, PJH Law

Pharmaflow consultant Hedley Rees points out in his expert report for PJH Law that UK regulators the MHRA do not have the skill set to regulate medicines, let alone these experimental gene therapies. Also that the supply chain is not being monitored and that there is no quality control whatever in the production of these experimental vaccines. Glossary Of Terms Summary Safety Of Final Product And Supply Chain Non-compliance With Gmdp Conflicts Of Interest And Lack Of Experience In The Mhra Steps For Mrha To Take Stages Involved In Developing A New Medicine Globally Harmonised Process For Developing A New Medicine Advanced Therapy Medicinal Products The Process Of Licensing Supply Chain For Distribution Of Sars-cov-2 Injections Summary Of Gmp Obligations Of A Clinical Trial Sponsor (Cts) Or Marketing Authorisation Holder (Mah) Transfer Of Ownership To The Distribution Channel Initial Further Assessment Of Issues And Concerns Annex 1: Profiles Of Mhra Board Members Expert Report Prepared By Hedley Rees Managing Consultant At Pharmaflow Limited Dated 17th December 2021

https://politicsthisweek.wordpress.com/2022/01/27/not-the-bcfm-politics-show-presented-by-tony-gosling-74/